Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.81 USD | +1.61% | +4.63% | +35.54% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.54% | 550M | |
-2.10% | 89.08B | |
+2.76% | 40.9B | |
-12.92% | 32.25B | |
+54.69% | 25.14B | |
-16.51% | 15.39B | |
-8.27% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- RBC Cuts Price Target on Avid Bioservices to $17 From $20, Cites Softer-Than-Expected Revenue Guidance; Outperform Kept